BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28817437)

  • 41. Guidelines for extended lymphadenectomy in gastric cancer: a prospective comparative study.
    Asoglu O; Matlim T; Kurt A; Onder SY; Kunduz E; Karanlik H; Sam B; Kapran Y; Bugra D
    Ann Surg Oncol; 2013 Jan; 20(1):218-25. PubMed ID: 22851047
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma.
    Fu S; Lu JJ; Zhang Q; Yang Z; Peng L; Xiong F
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1488-94. PubMed ID: 18538489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
    Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK
    Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Surgical therapy of non-Hodgkin lymphoma of the stomach].
    Zippel K; Agnes A; Zieren HU
    Zentralbl Chir; 1998; 123(1):53-7. PubMed ID: 9542031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lymph node dissection in resectable advanced gastric cancer.
    de Steur WO; Dikken JL; Hartgrink HH
    Dig Surg; 2013; 30(2):96-103. PubMed ID: 23867585
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative analysis of station-specific lymph node yield in laparoscopic and open distal gastrectomy for early gastric cancer.
    Bouras G; Lee SW; Nomura E; Tokuhara T; Tsunemi S; Tanigawa N
    Surg Laparosc Endosc Percutan Tech; 2011 Dec; 21(6):424-8. PubMed ID: 22146165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI.
    Al-Batran SE; Goetze TO; Mueller DW; Vogel A; Winkler M; Lorenzen S; Novotny A; Pauligk C; Homann N; Jungbluth T; Reissfelder C; Caca K; Retter S; Horndasch E; Gumpp J; Bolling C; Fuchs KH; Blau W; Padberg W; Pohl M; Wunsch A; Michl P; Mannes F; Schwarzbach M; Schmalenberg H; Hohaus M; Scholz C; Benckert C; Knorrenschild JR; Kanngießer V; Zander T; Alakus H; Hofheinz RD; Roedel C; Shah MA; Sasako M; Lorenz D; Izbicki J; Bechstein WO; Lang H; Moenig SP
    BMC Cancer; 2017 Dec; 17(1):893. PubMed ID: 29282088
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gastric cancer in Asia: progress and controversies in surgical management.
    Branicki FJ; Chu KM
    Aust N Z J Surg; 1998 Mar; 68(3):172-9. PubMed ID: 9563443
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intraarterial chemotherapy as an adjuvant treatment in locally advanced gastric cancer.
    Tentes AA; Markakidis SK; Karanikiotis C; Fiska A; Tentes IK; Manolopoulos VG; Dimitriou T
    Langenbecks Arch Surg; 2006 Apr; 391(2):124-9. PubMed ID: 16534653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biopathologic features and clinical significance of micrometatasis in the lymph node of early gastric cancer.
    Jo MJ; Park JY; Song JS; Kook MC; Ryu KW; Cho SJ; Lee JH; Nam BH; Hong EK; Choi IJ; Kim YW
    World J Gastroenterol; 2015 Jan; 21(2):667-74. PubMed ID: 25593497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors influencing noncompliance and contamination in a randomized trial of "Western" (r1) versus "Japanese" (r2) type surgery in gastric cancer.
    Bunt TM; Bonenkamp HJ; Hermans J; van de Velde CJ; Arends JW; Fleuren G; Bruijn JA
    Cancer; 1994 Mar; 73(6):1544-51. PubMed ID: 8156481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Quality control of radical lymphadenectomy for gastric cancer].
    Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jul; 20(7):726-730. PubMed ID: 28722081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of gastric cancer.
    Moehler M; Galle PR; Gockel I; Junginger T; Schmidberger H
    Best Pract Res Clin Gastroenterol; 2007; 21(6):965-81. PubMed ID: 18070698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.
    Qian J; Qian Y; Wang J; Gu B; Pei D; He S; Zhu F; Røe OD; Xu J; Liu L; Gu Y; Guo R; Yin Y; Shu Y; Chen X
    Drug Des Devel Ther; 2016; 10():241-58. PubMed ID: 26966350
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?
    Reddavid R; Sofia S; Chiaro P; Colli F; Trapani R; Esposito L; Solej M; Degiuli M
    World J Gastroenterol; 2018 Jan; 24(2):274-289. PubMed ID: 29375213
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery.
    Morgan JW; Ji L; Friedman G; Senthil M; Dyke C; Lum SS
    JAMA Surg; 2015 Jan; 150(1):37-43. PubMed ID: 25426671
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Multimodal therapy in patients with advanced gastric cancer].
    Otto F
    MMW Fortschr Med; 2008 May; 150(19):31-3. PubMed ID: 18589912
    [No Abstract]   [Full Text] [Related]  

  • 58. [Characteristics of recurrence in patients with gastric cancer after radical gastrectomy and adjuvant chemotherapy].
    Du C; Guo C; Xu Q; Wang J; Zhou A
    Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):622-7. PubMed ID: 26714605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adjuvant chemoradiation versus chemotherapy in completely resected advanced gastric cancer with D2 nodal dissection.
    Kwon HC; Kim MC; Kim KH; Jang JS; Oh SY; Kim SH; Kwon KA; Lee S; Lee HS; Kim HJ
    Asia Pac J Clin Oncol; 2010 Dec; 6(4):278-85. PubMed ID: 21114777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase II study of docetaxel and S-1 (DS) as neoadjuvant chemotherapy for clinical stage III resectable gastric cancer.
    Oki E; Emi Y; Kusumoto T; Sakaguchi Y; Yamamoto M; Sadanaga N; Shimokawa M; Yamanaka T; Saeki H; Morita M; Takahashi I; Hirabayashi N; Sakai K; Orita H; Aishima S; Kakeji Y; Yamaguchi K; Yoshida K; Baba H; Maehara Y
    Ann Surg Oncol; 2014 Jul; 21(7):2340-6. PubMed ID: 24604583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.